Why this broker thinks the Metcash (ASX:MTS) share price is great value

Is this ASX share great value right now?

| More on:
Smiling female investor holds hands up in victory in front of a laptop

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Metcash Limited (ASX: MTS) share price was on form on Tuesday and pushed higher.

The wholesales distributor's shares rose just over 2% to $3.68. This means the Metcash share price is now up 28% since this time last year.

Why did the Metcash share price push higher?

As well as getting a lift from a broad market rebound today, the Metcash share price was boosted by a broker note out of Goldman Sachs.

According to the note, the broker has retained its buy rating and $3.95 price target on its shares.

Based on the current Metcash share price, this price target implies potential upside of 7.3% over the next 12 months excluding dividends. Including them, the potential return stretches to approximately 12.5%.

What did the broker say?

Goldman Sachs appears confident that Metcash will deliver a strong full year result for FY 2021 next week.

The broker is forecasting an 8.2% increase in revenue of $14,088 million for the 12 months. Goldman expects this to be driven by a 10.3% rise in Supermarket sales, a 17% jump in Liquor sales, and a 20.5% increase in Hardware sales. However, this will be offset slightly by a 32% decline in Convenience sales following the loss of contracts.

In respect to earnings, its analysts are expecting Metcash's underlying earnings before interest and tax (EBIT) to come in at $432.3 million, which is up 33.3% on the prior corresponding period.

Finally, on the bottom line, an underlying profit after tax of $281.5 million is being forecast by Goldman Sachs. This will be a 34% increase on FY 2020's underlying profit after tax of $209.7 million.

Based on its expectations for FY 2021, the Metcash share price is currently trading at 13x full year earnings. Though, it is worth noting that the company's earnings are forecast to soften in FY 2022 before growing again in FY 2023. This means its shares are actually trading at 15x FY 2022 earnings based on the broker's forecasts.

Still, based on its recommendation, this appears to be a level that the broker thinks is attractive and offers a compelling risk/reward.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »